Analysts trimmed their target on JBL to $425 from $427 on Wednesday, a modest cut for a contract manufacturer that sits at the heart of the tech supply chain. Taiwan's August export orders hit $103bn, up 71% from the prior record, underscoring the demand surge that feeds Jabil's order books. The slight downgrade may reflect margin concerns rather than any demand worry.
SNPS was the standout riser. Analysts lifted the EDA software maker's consensus target to $563 from $554, a near-$10 swing that reflects growing confidence in AI-driven chip design spending. Synopsys carries a short interest of just 3% of free float, suggesting the bears are not fighting this one.
DXCM also drew a target upgrade, moving to $95 from $94. The continuous glucose monitor maker has been recovering from last year's revenue miss, and analysts appear to be rebuilding conviction.
CI and HRL both absorbed small target cuts. Cigna dropped to $341 from $342, and Hormel fell to $25.94 from $26.13. Neither cut signals alarm, but both names are under steady pressure.
MU saw a single recommendation removed, leaving its consensus unchanged at 44 buys. With Taiwan's record export orders pointing to robust semiconductor demand, analysts appear reluctant to turn negative on memory.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
